Insight

Latest California Healthline Stories

The Real Costs of the New Alzheimer’s Drug, Most of Which Will Fall to Taxpayers

The annual cost of lecanemab treatment quadruples if the expense of brain scans to monitor for bleeds and other associated care is factored in. The full financial toll likely puts it beyond reach for low-income seniors at risk of Alzheimer’s, experts say.

Medical Debt Is Making Americans Angry. Doctors and Hospitals Ignore This at Their Peril.

Doctors and hospitals hold an exalted position in American life, retaining public confidence even as other institutions such as government, law enforcement, and the media are losing people’s trust. But with health care debt out of hand, medical providers risk their good standing.

Industry Groups Vie for New Medi-Cal Money

State officials have promised to boost funding for California’s Medicaid program by $11.1 billion starting next year, with most of that money earmarked for higher payments to doctors, hospitals, and other providers. But the details have yet to be worked out, and powerful health industry groups are jockeying for position.